RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:From $0.52 to $28.00 in 12 months or $3.5 to $23 in 3 monthsmisleading for sure especially when Matt himself said that he expected to be running 2 phase 3 trials starting in 2023. Now it's anticipation for panc and only guidance for the phase 3. Not making any of this up,just the facts. And quentin is right , they could have started the trial 6 years ago and even stated such in their older pr's if you care to actually take a look.
I'll make you a bet, I bet when the circular for the AGM comes out the Management gives themselves another well deserved raise. Now that's taking care of the shareholders and adding value for sure. The addition on the bod is good but at the same time they should have gotten rid of at least one yes person who has no shares or interest in the company IMO.
As for MM's controlling the price, you don't even need them for the price to go down, there is just no shareholder support as we have no institutions other than a hedge fund to support the price.
Let's see if they actually start the phase 3 this june with a partner.